Regulatory Guidance Monthly Review - November 2020
November 2020
Each month, Veristat's regulatory team tracks and shares a selection of new...
Regulatory Guidance Monthly Review - October 2020
October 2020
Each month, Veristat's regulatory team tracks and shares a selection of new...
Regulatory Guidance Monthly Review - September 2020
September 2020
Each month, Veristat's regulatory team tracks and shares a selection of new...
Regulatory Guidance Monthly Review - August 2020
August 2020
Each month, Veristat's regulatory team tracks and shares a selection of new...
Regulatory Guidance Monthly Review - July 2020
July 2020
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory...
Regulatory Guidance Monthly Review - June 2020
June 2020
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory...
Regulatory Guidance Monthly Review - May 2020
MAY 2020
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory...
EMA Guidance on Management of Clinical Trials during COVID-19 Pandemic
Summary of Key Considerations Outlined in the Third Edition of the EMA Guidance
The European...
Clinical Trial Conduct During COVID-19 Pandemic Response
Key Lessons Learned during the First Month of the COVID-19 Pandemic Response
As we are well-rooted...
Regulatory Guidance Monthly Review - April 2020
April 2020
Each month, Veristat's regulatory team tracks and shares a selection of new...